The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Electrophysiological and Morphological Changes in Striatal Spiny Neurons in R6/2 Huntington's Disease Transgenic Mice
Abstract
We examined passive and active membrane properties and synaptic responses of medium-sized spiny striatal neurons in brain slices from presymptomatic (∼40 days of age) and symptomatic (∼90 days of age) R6/2 transgenics, a mouse model of Huntington's disease (HD) and their age-matched wild-type (WT) controls. This transgenic expresses exon 1 of the human HD gene with ∼150 CAG repeats and displays a progressive behavioral phenotype associated with numerous neuronal alterations. Intracellular recordings were obtained using standard techniques from R6/2 and age-matched WT mice. Few electrophysiological changes occurred in striatal neurons from presymptomatic R6/2 mice. The changes in this age group were increased neuronal input resistance and lower stimulus intensity to evoke action potentials (rheobase). Symptomatic R6/2 mice exhibited numerous electrophysiological alterations, including depolarized resting membrane potentials, increased input resistances, decreased membrane time constants, and alterations in action potentials. Increased stimulus intensities were required to evoke excitatory postsynaptic potentials (EPSPs) in neurons from symptomatic R6/2 transgenics. These EPSPs had slower rise times and did not decay back to baseline by 45 ms, suggesting a more prominent component mediated by activation of N-methyl-d-aspartate receptors. Neurons from both pre- and symptomatic R6/2 mice exhibited reduced paired-pulse facilitation. Data from biocytin-filled or Golgi-impregnated neurons demonstrated decreased dendritic spine densities, smaller diameters of dendritic shafts, and smaller dendritic fields in symptomatic R6/2 mice. Taken together, these findings indicate that passive and active membrane and synaptic properties of medium-sized spiny neurons are altered in the R6/2 transgenic. These physiological and morphological alterations will affect communication in the basal ganglia circuitry. Furthermore, they suggest areas to target for pharmacotherapies to alleviate and reduce the symptoms of HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Ionic channels of excitable membranes
(1985) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(85)90172-7 · Cited by 6,982
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Short-Term Synaptic Plasticity
Zucker, R. S. (1989) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.12.030189.000305 · Cited by 1,447
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Heterogeneity of release probability, facilitation, and depletion at central synapses
Dobrunz, L. E., & Stevens, C. F. (1997) · Neuron · doi:10.1016/s0896-6273(00)80338-4 · Cited by 1,183
David Smith, A., & Paul Bolam, J. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90106-k · Cited by 1,036
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
Hodgson, J. G., Agopyan, N., Gutekunst, C.-A., Leavitt, B. R., LePiane, F., Singaraja, R., Smith, D. J., Bissada, N., McCutcheon, K., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 830
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Luthi-Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 720
Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
Portera-Cailliau, C., Hedreen, J., Price, D., & Koliatsos, V. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03775.1995 · Cited by 607
Fonnum, F., Storm-Mathisen, J., & Divac, I. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90168-8 · Cited by 542
Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., & Young, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6480 · Cited by 504
Structural and quantitative studies on the normal C3H and lurcher mutant mouse
Caddy, K. W. T., & Biscoe, T. J. (1979) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1979.0055 · Cited by 484
Energetics in the pathogenesis of neurodegenerative diseases
Beal, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01584-8 · Cited by 474
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., & Davies, S. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110078997 · Cited by 430
Replicating Huntington's disease phenotype in experimental animals
Brouillet, E. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00005-2 · Cited by 413
Reddy, P. H., Williams, M., Charles, V., Garrett, L., Pike-Buchanan, L., Whetsell, W. O., Miller, G., & Tagle, D. A. (1998) · Nature Genetics · doi:10.1038/2510 · Cited by 399
Murphy, K. P. S. J., Carter, R. J., Lione, L. A., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05115.2000 · Cited by 398
Transcriptional dysregulation in Huntington’s disease
Cha, J.-H. J. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01609-x · Cited by 397
Lione, L. A., Carter, R. J., Hunt, M. J., Bates, G. P., Morton, A. J., & Dunnett, S. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10428.1999 · Cited by 384
Motor disorder in Huntington's disease begins as a dysfunction in error feedback control
Smith, M. A., Brandt, J., & Shadmehr, R. (2000) · Nature · doi:10.1038/35000576 · Cited by 354
Levine, M. S., Klapstein, G. J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M. E., Jokel, E. S., Carpenter, E. M., Zanjani, H., Hurst, R. S., et al. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<515::aid-jnr5>3.0.co;2-f · Cited by 352
Self-citationMitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse
Tabrizi, S. J., Workman, J., Hart, P. E., Mangiarini, L., Mahal, A., Bates, G., Cooper, J. M., & Schapira, A. H. V. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1<80::aid-ana13>3.0.co;2-k · Cited by 351
Nisenbaum, E., & Wilson, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-06-04449.1995 · Cited by 348
Trinucleotide Repeats in Neurogenetic Disorders
Paulson, H. L., & Fischbeck, K. H. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.000455 · Cited by 333
Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract
McGeer, E. G., McGeer, P. L., & Singh, K. (1978) · Brain Research · doi:10.1016/0006-8993(78)90941-1 · Cited by 325
Mouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Self-citationSevere deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
Bibb, J. A., Yan, Z., Svenningsson, P., Snyder, G. L., Pieribone, V. A., Horiuchi, A., Nairn, A. C., Messer, A., & Greengard, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120166397 · Cited by 289
Kita, H., & Armstrong, W. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90124-i · Cited by 231
Impaired Synaptic Plasticity in Mice Carrying the Huntington's Disease Mutation
Usdin, M. T., Shelbourne, P. F., Myers, R. M., & Madison, D. V. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.839 · Cited by 230
Hansson, O., Petersén, Å., Leist, M., Nicotera, P., Castilho, R. F., & Brundin, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8727 · Cited by 228
Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex
Polidori, M. C., Mecocci, P., Browne, S. E., Senin, U., & Beal, M. F. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00578-9 · Cited by 211
The complex pathology of trinucleotide repeats
Reddy, P. S., & Housman, D. E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80009-9 · Cited by 187
Dopamine-dependent synaptic plasticity in striatum during in vivo development
Tang, K.-C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031374698 · Cited by 171
Sapp, E., Penney, J., Young, A., Aronin, N., Vonsattel, J.-P., & DiFiglia, M. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00006 · Cited by 171
Harris, G. J., Codori, A. M., Lewis, R. F., Schmidt, E. U., Bedi, A., & Brandt, J. (1999) · Brain · doi:10.1093/brain/122.9.1667 · Cited by 155
Decrease in Striatal Enkephalin mRNA in Mouse Models of Huntington’s Disease
Menalled, L., Zanjani, H., Mackenzie, L., Koppel, A. B., Carpenter, E. M., Zeitlin, S., & Chesselet, M. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7327 · Cited by 133
Self-citationBioenergetics in Huntington's Disease
Grünewald, T. G. P., & Beal, M. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07827.x · Cited by 110
Butterworth, N. J., Williams, L. C., Bullock, J. Y., Love, D. R., Faull, R. L. M., & Dragunow, M. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00129-8 · Cited by 96
Vulnerability of Medium Spiny Striatal Neurons to Glutamate: Role of Na+/K+ ATPase
Calabresi, P., Murtas, M. D., Pisani, A., Stefani, A., Sancesario, G., Mercuri, N. B., & Bernardi, G. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00689.x · Cited by 80
Are there multiple pathways in the pathogenesis of Huntington's disease?
Aronin, N., Kim, M., Laforet, G., & DiFiglia, M. (1999) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1999.0451 · Cited by 64
The Genetic Defect Causing Huntington’s Disease: Repeated in Other Contexts?
Gusella, J. F., Persichetti, F., & MacDonald, M. E. (1997) · Molecular Medicine · doi:10.1007/bf03401677 · Cited by 60
Morton, A. J., & Leavens, W. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00238-0 · Cited by 59
Haddad, M. S., & Cummings, J. L. (1997) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70345-2 · Cited by 49
Age-induced changes in electrophysiological responses of neostriatal neurons recorded in vitro
Cepeda, C., Lee, N., Buchwald, N. A., Radisavljevic, Z., & Levine, M. S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90325-v · Cited by 32
Self-citation
Research works printed but not linked: 3
- Ariano MA, 2000, Soc Neurosci Abstr, 26, 1030
- Centonze D, 2000, Funct Neurol, 15, 253
- 10.1073/pnas.98.3.1255 · doi:10.1073/pnas.98.3.1255 · Paper page
Cited by
Striatal Plasticity and Basal Ganglia Circuit Function
Kreitzer, A. C., & Malenka, R. C. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.005 · Cited by 1,017
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913
Self-citationTong, X., Ao, Y., Faas, G. C., Nwaobi, S. E., Xu, J., Haustein, M. D., Anderson, M. A., Mody, I., Olsen, M. L., Sofroniew, M. V., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3691 · Cited by 592
Menalled, L. B., Sison, J. D., Dragatsis, I., Zeitlin, S., & Chesselet, M. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10776 · Cited by 536
Self-citationN-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
FAN, M., & RAYMOND, L. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.003 · Cited by 413
Metadata
- Authors
- Klapstein, G. J., Fisher, R. S., Zanjani, H., Cepeda, C., Jokel, E. S., Chesselet, M.-F., & Levine, M. S.
- Venue
- Journal of Neurophysiology
- Publisher
- American Physiological Society
- Published
- 2001-12-01
- Volume
- 86
- Issue
- 6
- Pages
- 2667-2677
- ISSN
- 0022-3077 (ISSN-L)
- 1522-1598
- OpenAlex
- W1767788740
- Cited by
- 314
- References
- 49
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.